Author
Denali Therapeutics (United States)Primary ORCID profile (0000-0002-1302-8032 · 5 papers)Unclaimed ORCID profile · follow to get notified of new preprints
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
2 papers
Recent·Most cited
Robert C. Wells, Padma Akkapeddi, Darren Chan…·Kylie S. Chew
This paper demonstrates that dual targeting of TfR and CD98hc enhances brain exposure of large molecules compared to single-target approaches.
Michelle E. Pizzo, Edward D. Plowey, Nathalie Khoury…·Y. Joy Yu Zuchero
This study develops an antibody transport vehicle targeting the transferrin receptor to improve brain delivery of anti-amyloid antibodies, reducing ARIA-like lesions and vascular inflammation in a mouse model.